Organization
Universitair Ziekenhuis Brussel
20 clinical trials
4 abstracts
Abstract
A multicenter randomized controlled trial (RCT) for the effectiveness of Comprehensive Geriatric Assessment (CGA) with extensive patient coaching on quality of life (QoL) in older patients with solid tumors receiving systemic therapy: G-oncoCOACH study.Org: University Hospitals Leuven, Leuven, Belgium, Academic Centre for Nursing and Midwifery, Universitair Ziekenhuis Brussel, European Medicines Agency, Department of Public Health and Primary Care,
Clinical trial
Phase I/IIa Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of 68GaNOTA-Anti-MMR-VHH2, a New Radiopharmaceutical for in Vivo Imaging of Tumour-Associated Macrophages by Means of PET : UZBRU_VHH2_1Status: Recruiting, Estimated PCD: 2024-10-01
Abstract
A phase 2 clinical trial of regorafenib in patients with advanced pretreated melanoma (RegoMel).Org: Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel,
Clinical trial
TraMel-WT: A Stratified Dual-stratum Open-label Two-stage Phase 2 Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type MelanomaStatus: Completed, Estimated PCD: 2023-06-30
Clinical trial
The Circadian Variability of Serum Progesterone During the Day of a Frozen Embryo Transfer in an Artificially Prepared Cycle and in a Modified Natural CycleStatus: Completed, Estimated PCD: 2023-12-01
Clinical trial
Dose-limiting Toxicities of Paclitaxel in Breast Cancer Patients: Studying Interactions Between Pharmacokinetics, Physical Activity, and Body Composition: an Observational Pilot Study.Status: Not yet recruiting, Estimated PCD: 2025-05-06
Clinical trial
Evaluation of 68GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer PatientsStatus: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
Quantification of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Metastasis of Breast Carcinoma Patients and Assessment of Repeatability (VUBAR) - Pilot StudyStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
The Multi-disciplinary Approach of Children With Feeding Difficulties and Tube Feeding in UZB Between 2000 and 2021: a Retrospective Cohort StudyStatus: , Estimated PCD: 2024-09-30
Clinical trial
Phase II Study to Evaluate the Clinical Potential of 68GaNOTA-Anti-MMR-VHH2 for in Vivo Imaging of MMR-expressing Macrophages by Means of Positron Emission Tomography (PET) in Oncological Lesions,Cardiovascular Atherosclerosis,Syndrome With Abnormal Immune Activation and sarcoïdosisStatus: Recruiting, Estimated PCD: 2025-01-26
Clinical trial
A Phase-2 Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma - Definition of Two Additional Stratified Patient Cohorts of Regorafenib Plus BRAF-/MEK-inhibitors in Pretreated BRAF V600-mutant Melanoma PatientsStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Phase I Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent GlioblastomaStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Clinical trial
Phase I Clinical Trial on Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent GlioblastomaStatus: , Estimated PCD: 2023-11-17
Clinical trial
A Phase II Study to Evaluate the Imaging Potential of 68GaNOTA-Anti-MMR VHH2 for in Vivo Imaging of MMR-expressing Macrophages by Means of Positron Emission Tomography (PET) in Patients With Non-small Cell Lung Cancer (NSCLC)Status: Recruiting, Estimated PCD: 2027-04-01
Clinical trial
DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation in Breast Cancer Patients Undergoing Fertility Preservation: a Pilot StudyStatus: Recruiting, Estimated PCD: 2025-11-30
Clinical trial
Initiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola®) in the Late Follicular Phase, a Randomised Controlled Pilot Study.Status: Completed, Estimated PCD: 2022-05-27
Clinical trial
Efficacy of Ulipristalacetate in Comparison to Surgery Before IVF/ICSI-treatment in Women With Intramural Fibroids: Effect on Reproductive Outcome.Status: Active (not recruiting), Estimated PCD: 2025-12-31
Clinical trial
Sub-type Specific Genomic Mutations in Serous Borderline Ovarian TumorsStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Comparison Between Corifollitropin Alfa and Recombinant FSH for Follicular Recruitment in Women With Polycystic Ovaries Who Undergo IVM TreatmentStatus: Completed, Estimated PCD: 2022-12-31
Clinical trial
Serratus Anterior Plane Block or Erector Spinae Plane Block Used as an Adjuvant for Hybrid Arrhythmia Ablation SurgeryStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Incidence of Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the Intensive Care Unit: a Retrospective AnalysisStatus: Completed, Estimated PCD: 2023-04-01
Abstract
First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): 64-month (mo) follow-up from CheckMate 142.Org: University of Southern California Norris Comprehensive Cancer Center, MD Anderson Cancer Center, University Hospitals Gasthuisberg/Leuven and KU Leuven, Hospital Universitario Virgen del Rocio, Westmead Hospital,
Abstract
Combination of regorafenib with BRAF-/MEK-inhibitors for the treatment of patients with refractory melanoma brain metastases.Org: Universitair Ziekenhuis Brussel, Netherlands Cancer Institute, Department of Medical Oncology, Vrije Universiteit Brussel (VUB)/ Universitair Ziekenhuis Brussel (UZ Brussel),